PhD student Fabian Kurth has accepted a position at Accenture, a leading global management, consulting and outsourcing services organisation.

IMB scientist is part of an international team awarded $US1.3 million to help identify how fat deposits in humans can be used to attack bacteria. UQ Institute for Molecular Bioscience scientist Professor Robert Parton is one of only two Australian-based researchers to get 2015 Human Frontier Science Program funding.

IMB Advisory Board formed to assist in guiding IMB’s operations as a leader in research, commercialisation, philanthropic and engagement activities.

Professor Kirill Alexandrov has been awarded a 2015 NBCF Innovator Grant to investigate the potential of a new diagnostic test for advanced breast cancer. ­

The NHMRC has awarded IMB's Professor David Fairlie $557,000 over three years to develop new drug treatments for malaria, a disease that kills an estimated 584,000 people worldwide each year.

Professor Matthew Cooper and Dr Mark Butler have received the prestigious JA Medal for a review the pair authored titled ‘Antibiotics in the Clinical Pipeline in 2011’.

UQ’s Institute for Molecular Bioscience (IMB) and Australian Institute for Bioengineering and Nanotechnology (AIBN) are inviting interested locals to join them for a public author event from 5.30pm on Wednesday 1 April to celebrate Penguin Random House’s upcoming new release.

UQ scientists have brought a retired sex gene in mammals back to life, proving it can still switch on male development in mice despite not having done so for millions of years.

A University of Queensland research team has been awarded a grant from The Michael J. Fox Foundation for Parkinson’s Research to target brain inflammation in people with Parkinson’s disease.